Vaccination News

The FDA on Monday approved Moderna’s COVID-19 vaccine, making it the second fully approved COVID-19 vaccine in the United States.

People previously infected with SARS-CoV-2 are substantially protected against COVID-19 for several months, even in the absence of vaccination, a study found.

The AAP urged that school districts prioritize in-person learning in updates to their interim pandemic guidance published today.

Data show that prenatal syphilis screening, although required by law in some states and recommended by the U.S. Preventive Services Task Force and CDC, has not reached 100% among Medicaid recipients in six Southern states.

Moderna on Wednesday announced the start of a phase 2 study of an omicron-specific COVID-19 booster shot.

Omicron has taxed the country’s health care system, causing more COVID-19 cases, ED visits and hospitalizations than any other variant during the pandemic, according to newly published data.

Pfizer and BioNTech said Tuesday that they have initiated a clinical study to assesses the safety and efficacy of a COVID-19 vaccine for adults aged 18 to 55 years that specifically targets the omicron variant of SARS-CoV-2.

Despite low absolute rates, researchers observed elevated odds of cardiac injury among male adolescents and young adults after messenger RNA-based COVID-19 vaccination in a large U.S. study, as well as a smaller study in Hong Kong.

A study published in JAMA Pediatrics reported high morbidity and mortality rates among hospitalized children and adolescents with COVID-19 in 6 sub-Saharan African countries, even among those who were otherwise healthy.

Data from three new studies confirmed that COVID-19 vaccine booster doses improved protection against the omicron variant.